Publication: Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus
| dc.contributor.author | BİNGÖL ÖZAKPINAR, ÖZLEM | |
| dc.contributor.authors | Ozlu, Emin; Karadag, Ayse Serap; Toprak, Aybala E.; Uzuncakmak, Tugba K.; Gerin, Fethullah; Aksu, Feyza; Ozakpinar, Ozlem; Akdeniz, Necmettin | |
| dc.date.accessioned | 2022-03-12T20:29:04Z | |
| dc.date.accessioned | 2026-01-11T10:29:33Z | |
| dc.date.available | 2022-03-12T20:29:04Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Background and Objective: The current study aimed to evaluate cardiovascular risk factors, haematological and biochemical parameters, and serum endocan concentrations in lichen planus (LP) patients. Methods: This study was conducted with 86 cases, including 43 LP patients and 43 healthy controls. Cardiovascular risk factors, haematological and biochemical parameters, and endocan levels were evaluated. Results: The serum endocan concentrations of LP patients were not significantly different from those of the healthy controls (p > 0.05). There were no significant differences in the serum endocan levels according to classification by cardiovascular risk factors and smoking history (p > 0.05). In the LP group, white blood cell count, platelet distribution width and monocyte count/high-density lipoprotein cholesterol ratios were significantly higher when compared to the healthy controls (p < 0.05). The LP group had a lower mean platelet volume than the healthy controls (p < 0.05). Conclusions: Serum endocan levels did not change significantly in patients with LP, and there were significant differences in haematological and biochemical parameters. (C) 2016 S. Karger AG, Basel | |
| dc.identifier.doi | 10.1159/000447587 | |
| dc.identifier.eissn | 1421-9832 | |
| dc.identifier.issn | 1018-8665 | |
| dc.identifier.pubmed | 27508489 | |
| dc.identifier.uri | https://hdl.handle.net/11424/234021 | |
| dc.identifier.wos | WOS:000384273900006 | |
| dc.language.iso | eng | |
| dc.publisher | KARGER | |
| dc.relation.ispartof | DERMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Biochemical parameters | |
| dc.subject | Cardiovascular risk factors | |
| dc.subject | Endocan | |
| dc.subject | Haematological parameters | |
| dc.subject | Lichen planus | |
| dc.subject | CELL SPECIFIC MOLECULE-1 | |
| dc.subject | PSORIASIS-VULGARIS | |
| dc.subject | LYMPHOCYTE RATIO | |
| dc.subject | CHOLESTEROL RATIO | |
| dc.subject | DISEASE | |
| dc.subject | PLATELET | |
| dc.subject | MARKER | |
| dc.subject | ASSOCIATION | |
| dc.subject | PREVALENCE | |
| dc.subject | NEUTROPHIL | |
| dc.title | Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 443 | |
| oaire.citation.issue | 4 | |
| oaire.citation.startPage | 438 | |
| oaire.citation.title | DERMATOLOGY | |
| oaire.citation.volume | 232 |
